Frequency Therapeutics, Inc.
COMBINATION OF CHIR99021 AND VALPROIC ACID FOR TREATING HEARING LOSS
Last updated:
Abstract:
Provided herein are compound(s) for use in treating sensorineural hearing loss in a human patient, for example, hair cell regeneration agent(s) for use in treating sensorineural hearing loss in a human. Also provided are methods of treating sensorineural hearing loss in a human by administering certain compound(s), for example, hair cell regeneration agent(s).
Status:
Application
Type:
Utility
Filling date:
8 Apr 2020
Issue date:
9 Jun 2022